RBM15 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 6.447800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
5.867400E-01
Normal-vs-Stage2
6.602800E-01
Normal-vs-Stage3
4.545600E-01
Normal-vs-Stage4
9.785400E-01
Stage1-vs-Stage2
4.802000E-01
Stage1-vs-Stage3
5.476500E-02
Stage1-vs-Stage4
3.996400E-02
Stage2-vs-Stage3
7.495700E-02
Stage2-vs-Stage4
3.897800E-02
Stage3-vs-Stage4
2.391800E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
6.341600E-01
Normal-vs-AfricanAmerican
8.055400E-01
Normal-vs-Asian
6.716600E-01
Caucasian-vs-AfricanAmerican
1.488590E-01
Caucasian-vs-Asian
6.770400E-01
AfricanAmerican-vs-Asian
4.025800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
6.269000E-01
Normal-vs-Female
6.693600E-01
Male-vs-Female
2.875000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
5.525400E-01
Normal-vs-Age(41-60Yrs)
7.262800E-01
Normal-vs-Age(61-80Yrs)
6.196400E-01
Normal-vs-Age(81-100Yrs)
5.542800E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
2.965600E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
6.051200E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
9.746600E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
1.929930E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
4.838000E-02
Age(61-80Yrs)-vs-Age(81-100Yrs)
3.338200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
5.989200E-01
Normal-vs-Daily Drinker
6.230200E-01
Normal-vs-Weekly Drinker
5.824800E-01
Normal-vs-Occasional Drinker
7.087000E-01
Normal-vs-Social Drinker
6.383000E-01
Non Drinker-vs-Daily Drinker
7.379400E-01
Non Drinker-vs-Weekly Drinker
8.193000E-01
Non Drinker-vs-Occasional Drinker
1.628810E-01
Non Drinker-vs-Social Drinker
6.090400E-01
Daily Drinker-vs-Weekly Drinker
6.149400E-01
Daily Drinker-vs-Occasional Drinker
3.158600E-01
Daily Drinker-vs-Social Drinker
8.533000E-01
Weekly Drinker-vs-Occasional Drinker
1.457220E-01
Weekly Drinker-vs-Social Drinker
4.810400E-01
Occasional Drinker-vs-Social Drinker
4.209200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
1.918570E-01
Normal-vs-Grade 2
3.379700E-02
Normal-vs-Grade 3
1.769720E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
2.837900E-02
Grade 1-vs-Grade 3
4.792000E-01
Grade 1-vs-Grade 4
1.918570E-01
Grade 2-vs-Grade 3
2.968400E-02
Grade 2-vs-Grade 4
3.379700E-02
Grade 3-vs-Grade 4
1.769720E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
6.093600E-01
Normal-vs-NonDiabetic
6.397400E-01
Diabetic-vs-NonDiabetic
5.160200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
7.130200E-01
Normal-vs-NoPancreatitis
6.313000E-01
Pancreatitis-vs-NoPancreatitis
3.305800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
6.184800E-01
Normal-vs-N1
6.649600E-01
N0-vs-N1
2.871600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
7.169200E-01
Normal-vs-TP53-NonMutant
6.310000E-01
TP53-Mutant-vs-TP53-NonMutant
1.508630E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
